| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/28/2008 | US20080206250 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206241 rheumatoid arthritis; e.g., a GM-CSF antibody, and an anti-folate compounds, e.g., methotrexate; but in an amount that does not induce neutropenia |
| 08/28/2008 | US20080206237 Synergistic Combination Of Xolair/Omalizumab/E25 With Immunosuppressive Agent |
| 08/28/2008 | US20080206210 gene therapy by intrathymic administration; lentiviral vectors |
| 08/28/2008 | US20080206208 Adipose tissue culture use in treatment and prevention of cardiomyopathies; tissue engineering; regenerative medicine |
| 08/28/2008 | US20080206190 Glycosylated IL-7, Preparation And Uses |
| 08/28/2008 | US20080206170 Creatine compositions for skin treatment |
| 08/28/2008 | US20080206143 Blockade of Elr+Cxc Chemokines as a Treatment For Inflammatory and Autoimmune Disease |
| 08/28/2008 | CA2678863A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | CA2678749A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | CA2678409A1 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides |
| 08/28/2008 | CA2678146A1 Compounds of formula (i) as serine protease inhibitors |
| 08/28/2008 | CA2676786A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/27/2008 | EP1961823A1 Fermentation and culture method, fermented plant extract, composition containing fermented plant extract, method for producing lipopolysaccharide and lipopolysaccharide |
| 08/27/2008 | EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer |
| 08/27/2008 | EP1961814A1 Recombinant polyvalent vaccine |
| 08/27/2008 | EP1961811A1 Novel cytokine ZCYTOR17 ligand |
| 08/27/2008 | EP1961768A1 Recombinant IL-18 Antibodies useful in Treatment of IL-18 mediated Disorders |
| 08/27/2008 | EP1961756A1 Novel bisboron compound |
| 08/27/2008 | EP1961742A1 compounds of formula (I) as serine protease inhibitors |
| 08/27/2008 | EP1961734A1 Amine compound and use thereof for medical purposes |
| 08/27/2008 | EP1961427A2 Neisserial vaccine compositions comprising a combination of antigens |
| 08/27/2008 | EP1961413A1 Rapidly disintegratable oral tablet |
| 08/27/2008 | EP1960427A1 Multimeric fc receptor polypeptides |
| 08/27/2008 | EP1959997A2 Antagonists of hmgb1 and/or rage and methods of use thereof |
| 08/27/2008 | EP1959990A2 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 08/27/2008 | EP1959989A2 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 08/27/2008 | EP1959950A1 Combination of an immunosuppressant and a ppar gamma agonist for the treatment of an undesirable immune response |
| 08/27/2008 | EP1905763A4 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 08/27/2008 | EP1474146B1 Phenylpyrimidine amines as ige inhibitors |
| 08/27/2008 | EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 08/27/2008 | EP1450804B1 Pharmaceutical formulations comprising an immune response modifier |
| 08/27/2008 | EP1384726B1 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1234025B1 Human enzymes of the metalloprotease family |
| 08/27/2008 | CN101253199A Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins |
| 08/27/2008 | CN101253178A Use of fused imidazole derivatives to mediate CCR3 related conditions |
| 08/27/2008 | CN101253173A Hydroxy substituted 1H-imidazopyridines and methods |
| 08/27/2008 | CN101252941A Treatment of inflammatory bowel disease |
| 08/27/2008 | CN101250528A Domestic pig proliferation inducing ligand cDNA as well as clone method and recombinant uses thereof |
| 08/27/2008 | CN101250527A Three-yellow chicken B lymphocyte stimulating factor cDNA as well as clone method and recombinant uses thereof |
| 08/27/2008 | CN101250502A Method for preparing evoked pluripotent stem cell |
| 08/27/2008 | CN101250236A Tuckahoe dextran phosphate esterified derivative as well as preparation and use thereof |
| 08/27/2008 | CN101249178A Reinforced immunity and kidney tonifying health care medicinal liquor and preparing same thereof |
| 08/27/2008 | CN101249157A Traditional Chinese medicine preparation for improving chicken immunity and antioxidant ability |
| 08/27/2008 | CN101249131A Gynostemma pentaphylla soft capsules preparations and method of preparing the same |
| 08/27/2008 | CN101249103A Tunny head immunological activity substance and method of preparing the same |
| 08/27/2008 | CN100413961C Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/27/2008 | CN100413514C Leaves of cajanus cajan(L.) millsp and extract, formulation and uses thereof |
| 08/27/2008 | CN100413510C Mannosan peptide injection and preparation method thereof |
| 08/27/2008 | CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 08/26/2008 | US7417058 Reacting cyanophenyl-4-sulfonylchloride with a piperidine-4-oxo in presence of ethylene glycol to form an intermediate, reducing cyano group, followed by amidation, then reacting with an amine to form sulfonamide end |
| 08/26/2008 | US7417046 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 08/26/2008 | US7417034 Pharmaceutically active uridine esters |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
| 08/26/2008 | US7416734 Vaccines for Mycoplasma bovis and methods of use |
| 08/26/2008 | US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use |
| 08/26/2008 | US7416726 Cytotoxicity; therapeutic antibody |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2392165C Vitamin d analogues |
| 08/26/2008 | CA2361614C Compositions for treating inflammatory response |
| 08/26/2008 | CA2347474C Bicyclic nitrogen heterocycles |
| 08/26/2008 | CA2343880C Polyketide synthase enzymes and recombinant dna constructs therefor |
| 08/26/2008 | CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase |
| 08/26/2008 | CA2208981C Novel trienoic retinoid compounds and methods |
| 08/26/2008 | CA2160779C Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 08/21/2008 | WO2008100995A1 Humanized anti-cd100 antibodies |
| 08/21/2008 | WO2008100912A1 Methods for attenuating allergen-induced airway hyperreactivity using cd1d dependent antagonists |
| 08/21/2008 | WO2008100635A1 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s |
| 08/21/2008 | WO2008100622A2 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100620A2 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100618A2 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100598A2 A method for enhancing t cell response |
| 08/21/2008 | WO2008100576A2 Sustained delivery formulations of rapamycin compounds |
| 08/21/2008 | WO2008100498A2 Treatment of inflammatory diseases using placental stem cells |
| 08/21/2008 | WO2008099928A1 Placental protein having action of regulating protease activity and its related gene |
| 08/21/2008 | WO2008099917A1 Agent for suppressing rejection in organ transplantation comprising anti-hmgb-1 antibody |
| 08/21/2008 | WO2008099188A1 Binding members for ige molecules |
| 08/21/2008 | WO2008098789A2 Dual acting prodrugs |
| 08/21/2008 | WO2008098749A2 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof |
| 08/21/2008 | WO2008098355A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 08/21/2008 | WO2008080091A3 Activation of rig-i pathway |
| 08/21/2008 | WO2008075349B1 Therapeutic methods using a thymus peptide |
| 08/21/2008 | WO2008057855A3 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity |
| 08/21/2008 | WO2008049424A3 Pharmaceutical composition for the treatment of allergic diseases |
| 08/21/2008 | US20080201122 Method and Apparatus for Computer Modeling of an Adaptive Immune Response |
| 08/21/2008 | US20080200543 side effects reduction; nontoxic; AIDS, a sepsis, anticancer agent; 1-oleoyl-2-2palmitoyl-3-acetylglycerol(R1/R2=9-octadecenoyl/hexadecanoyl; immune enhancing agent |
| 08/21/2008 | US20080200530 compound is a selective 5-HT2A inverse agonist or inhibits JC virus infection of human glial cells in patients with carcinomas, lymphoproliferative disorder, HIV, AIDS, immunosupressive therapy; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-fluoro-phenyl)-urea; pyrazole, urea or thiourea |
| 08/21/2008 | US20080200521 Novel hydroxamic acid containing amino acid derivatives |
| 08/21/2008 | US20080200511 Novel Compounds and Methods of Using the Same |
| 08/21/2008 | US20080200509 Utilizing such as 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide against cancer growth |
| 08/21/2008 | US20080200463 N-[5-(5-formyl-2-thienyl)-4-methyl-1,3-thiazol-2-yl]acetamide; autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer |
| 08/21/2008 | US20080200460 Chemical Compounds |
| 08/21/2008 | US20080200456 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine |
| 08/21/2008 | US20080200454 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | US20080200428 Antiproliferative Drug |